Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system
作者： Chao-Hsiun Tang , Raoh-Fang Pwu , I-Ching Tsai , Han-I Wang , San-Lin You
DOI: 10.1007/S00404-009-1218-6
关键词: Health care 、 Obstetrics 、 Total cost 、 Cervical cancer staging 、 Stage (cooking) 、 Cervical cancer 、 Indirect costs 、 Cervical intraepithelial neoplasia 、 Cancer 、 Gynecology 、 Medicine
摘要: Although cervical cancer is the most frequent for women in Taiwan, no examination of its treatment costs has yet been undertaken. This study aimed to investigate and precancerous lesion Taiwan. A total 7,398 cases intraepithelial neoplasia (CIN) lesions were identified from Taiwan Cervical Cancer Screening Registration System 2003. further 1,469 invasive (ICC) also a survey on staging information conducted by Task Force. Resource usage covering first 6 months after CIN diagnosis 5 years ICC extracted National Health Insurance claims database. The duration each visit transportation collected means personal interviews with CIN/ICC patients. mean standard deviation indirect estimated. average patients NT$4,201 CIN1, NT$8,623 CIN2 NT$14,406 CIN3, accounting 25–33% total. NT$210,230 Stage 1, NT$392,387 2, NT$433,969 3 NT$464,701 4, about 14–17% resulted considerable healthcare system Indirect associated such substantial cannot be ignored.
springer.com
uq.edu.au
elsevier.com参考文章(25)
V Hasselblad, J Hickey, S Datta, K Nanda, E Myers, D B Matchar, D C McCrory, L Bastian, Evaluation of cervical cytology. Evidence report/technology assessment (Summary). pp. 1- 6 ,(1999)
M. van Ballegooijen, M.A. Koopmanschap, J.D.F. Habbema, The management of cervical intra-epithelial neoplasia (CIN): Extensiveness and costs in The Netherlands European Journal of Cancer. ,vol. 31, pp. 1672- 1676 ,(1995) , 10.1016/0959-8049(95)00243-C
Bernard Benjamin, Health and vital statistics ,(1968)
Jeanne S Mandelblatt, William F Lawrence, Sharita Mizell Womack, Denise Jacobson, Bin Yi, Yi-ting Hwang, Karen Gold, James Barter, Keerti Shah, Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer JAMA. ,vol. 287, pp. 2372- 2381 ,(2002) , 10.1001/JAMA.287.18.2372
C. Bergeron, J.-G. Breugelmans, S. Bouée, C. Lorans, S. Bénard, V. Rémy, Coût du dépistage et de la prise en charge des lésions précancéreuses du col utérin en France Gynecologie Obstetrique & Fertilite. ,vol. 34, pp. 1036- 1042 ,(2006) , 10.1016/J.GYOBFE.2006.09.005
Constance Mao, Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler, Darron R. Brown, Dorothy J. Wiley, Frances B. Alvarez, Oliver M. Bautista, Kathrin U. Jansen, Eliav Barr, Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstetrics & Gynecology. ,vol. 107, pp. 18- 27 ,(2006) , 10.1097/01.AOG.0000192397.41191.FB
Scott B Cantor, Lawrence B Levy, Marylou Cárdenas-Turanzas, Karen Basen-Engquist, Tao Le, J Robert Beck, Michele Follen, None, Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer. Medical Decision Making. ,vol. 26, pp. 265- 272 ,(2006) , 10.1177/027298906288679
E. L. Franco, T. E. Rohan, L. L. Villa, Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer Journal of the National Cancer Institute. ,vol. 91, pp. 506- 511 ,(1999) , 10.1093/JNCI/91.6.506
R. E. Brown, J. G. Breugelmans, D. Theodoratou, S. Bénard, Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Current Medical Research and Opinion. ,vol. 22, pp. 663- 670 ,(2006) , 10.1185/030079906X99972
Mary S. Baker, Larry G. Kessler, Nicole Urban, Robert C. Smucker, Estimating the treatment costs of breast and lung cancer. Medical Care. ,vol. 29, pp. 40- 49 ,(1991) , 10.1097/00005650-199101000-00004